We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+7.16%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$7.42B
AUM Growth
+$1.24B
(+20%)
Cap. Flow
+$985M
Cap. Flow
% of AUM
13.27%
Top 10 Holdings %
Top 10 Hldgs %
10.68%
Holding
3,037
New
854
Increased
791
Reduced
777
Closed
600
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$49.3M |
| 2 |
Intuit
INTU
|
+$48.7M |
| 3 |
Costco
COST
|
+$47.9M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$47.4M |
| 5 |
Vanguard Real Estate ETF
VNQ
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$41M |
| 2 |
Dollar General
DG
|
+$39M |
| 3 |
Biogen
BIIB
|
+$36.8M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$29.8M |
| 5 |
Waste Management
WM
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Consumer Discretionary | 16.12% |
| 3 | Healthcare | 11.21% |
| 4 | Financials | 10.17% |
| 5 | Industrials | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AFI
2101
DELISTED
Armstrong Flooring, Inc.
AFI
| $196K | ﹤0.01% |
56,887
+21,333
| +60% | +$74.5K |
|
|
GMDA
2102
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
| $195K | ﹤0.01% |
+46,874
| New | +$200K |
|
2103
Grid Dynamics Holdings
GDYN
$476M
| $194K | ﹤0.01% |
25,151
-82,649
| -77% | -$597K |
|
2104
Exagen
XGN
$113M
| $194K | ﹤0.01% |
17,852
+3,997
| +29% | +$51.5K |
|
2105
Insteel Industries
IIIN
$633M
| $193K | ﹤0.01% |
10,309
-891
| -8% | -$16.8K |
|
|
FNHC
2106
DELISTED
FedNat Holding Company Common Stock
FNHC
| $193K | ﹤0.01% |
30,590
+10,720
| +54% | +$97.1K |
|
2107
BGSF Inc
BGSF
$59.1M
| $192K | ﹤0.01% |
+22,699
| New | +$218K |
|
2108
Clover Health Investments
CLOV
$2.28B
| $192K | ﹤0.01% |
+15,418
| New | +$171K |
|
|
DHC
2109
Diversified Healthcare Trust
DHC
$2.26B
| $192K | ﹤0.01% |
54,647
-113,983
| -68% | -$445K |
|
2110
CALL
HP
HPQ
$23.5B
| $192K | ﹤0.01% |
+10,100
| New | +$184K |
|
|
2111
PUT
HP
HPQ
$23.5B
| $192K | ﹤0.01% |
+10,100
| New | +$184K |
|
2112
Pebblebrook Hotel Trust
PEB
$2.16B
| $192K | ﹤0.01% |
+15,354
| New | +$184K |
|
|
CPRX
2113
DELISTED
Catalyst Pharmaceutical
CPRX
| $191K | ﹤0.01% |
+64,257
| New | +$251K |
|
2114
Televisa
TV
$1.45B
| $191K | ﹤0.01% |
30,945
-1,018
| -3% | -$6.2K |
|
|
CNH
2115
CNH Industrial
CNH
$13.8B
| $190K | ﹤0.01% |
+27,847
| New | +$185K |
|
2116
Crawford & Co Class A
CRD.A
$536M
| $189K | ﹤0.01% |
+28,826
| New | +$213K |
|
|
RDGT
2117
Ridgetech Inc
RDGT
$1.12M
| $189K | ﹤0.01% |
+5
| New | +$211K |
|
2118
Westwood Holdings Group
WHG
$182M
| $188K | ﹤0.01% |
+16,833
| New | +$207K |
|
2119
Milestone Scientific
MLSS
$34.5M
| $187K | ﹤0.01% |
+134,665
| New | +$235K |
|
2120
cbdMD
YCBD
$5.65M
| $187K | ﹤0.01% |
+259
| New | +$247K |
|
|
MYOV
2121
DELISTED
Myovant Sciences Ltd.
MYOV
| $187K | ﹤0.01% |
13,296
-7,657
| -37% | -$142K |
|
2122
Babcock & Wilcox
BW
$1.43B
| $186K | ﹤0.01% |
80,184
+57,696
| +257% | +$144K |
|
|
BBT
2123
Beacon Financial Corp
BBT
$2.53B
| $184K | ﹤0.01% |
+18,183
| New | +$179K |
|
2124
Customers Bancorp
CUBI
$2.59B
| $184K | ﹤0.01% |
16,400
-30,658
| -65% | -$364K |
|
2125
Alpha Pro Tech
APT
$50.4M
| $183K | ﹤0.01% |
+12,387
| New | +$210K |
|
Similar funds
Squarepoint's Q3 2020 Portfolio in Review
As of Q3 2020, Squarepoint held 3,037 positions worth $7.42B, up 20% from $6.18B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Squarepoint deployed $985M of net new capital in Q3 2020, opening 854 new positions and adding to 791 existing holdings. Its largest new stake was Salesforce: 186,017 shares worth $46.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Pfizer, an estimated $41M trimmed.
- Squarepoint's largest Q3 2020 buy was Salesforce: 186,017 shares worth $46.8M.
- Squarepoint added most to Visa in Q3 2020, an estimated $49.3M increase.
- Squarepoint's biggest Q3 2020 reduction was Pfizer, cutting an estimated $41M.
- Squarepoint fully exited Biogen in Q3 2020, selling an estimated $36.8M.
- Squarepoint's ten largest holdings make up 11% of its $7.42B portfolio in Q3 2020.
- Squarepoint opened 854 new positions and closed 600 in Q3 2020.
- Squarepoint's portfolio value rose 20% quarter-over-quarter to $7.42B.
Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.